Comparison Chart Outlook Therapeutics, Inc.
Stocks
OTLK
US69012T3059
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4882 USD | -2.36% |
|
-18.48% | -69.10% |
| 09-20 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to S&P Global BMI Index | CI |
| 08-27 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.36% | -18.48% | -69.10% | -62.73% | -98.84% | 119M |  |  | |
- Stock Market
- Stocks
- OTLK Stock
- Charts Outlook Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
